-
1.发明申请公开(公告)号：US20170247444A1
公开(公告)日：2017-08-31
申请号：US15421473
申请日：2017-02-01
发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka
IPC分类号： C07K16/24
CPC分类号： C07K16/241 , A61K2039/505 , A61K2039/545 , A61M5/003 , A61M5/31533 , A61M5/31573 , A61M5/31591 , A61P3/10 , A61P29/00 , C07K2317/21 , C07K2317/565
摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
-
公开(公告)号：US11124565B2
公开(公告)日：2021-09-21
申请号：US16540388
申请日：2019-08-14
发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka
摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
-
公开(公告)号：US10465003B2
公开(公告)日：2019-11-05
申请号：US15421473
申请日：2017-02-01
发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka
摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
-
4.发明申请公开(公告)号：US20190092849A1
公开(公告)日：2019-03-28
申请号：US16070385
申请日：2017-02-02
发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka
摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
-
-
-
搜索结果
4 条记录 (耗时 0.019 秒)
